With a shift in focus since the firm's founding in 1998 when the firm's focus was primarily in developing genomic research tools and oncology diagnostic products for cancer screening and therapy selection, Orion Genomics have developed to provide genomics research services and clinical laboratory services to leading healthcare and agricultural research organizations. Cstomers include biotechnology companies, pharmaceutical and diagnostics companies, agricultural and seed companies, government agencies and crop boards spanning four continents across the globe. Defining themselves as The Second Code Company, Orion Genomics was first established with the objective of expanding the reach and utility of the then nascent genomics technologies. The firm has grown to have established strategic partnerships and collaborations in the US, Europe and Southeast Asia. With three divisions -- Genomics Research and Services, Clinical Research and Services and Orion Biosains -- involves R&D scientists and bioinformaticians from around the world. Teams apply their expertise to develop alternative solutions and creative approaches to challenging issues in various industries such as human health and agriculture. With over 100 patents and patents pending, Orion Genomics has established itself as an innovator in the application and use of genetic and epigenetic technologies.